[Video Profile] Interview with Terrance Gregg, President & CEO of DexCom
DexCom is developing a short term continuous glucose monitor for people with diabetes. The Seven System’s probe-like sensor is inserted […]
Read more »One Small Step for Muscular Dystrophy Treatment Requires Giant Leap for FDA
Dr. Eric Hoffman of the Children’s National Medical Center predicts that individualized molecular therapies will be medicine’s next big innovation, […]
Read more »[Video Profile] Interview with E. Kevin Hrusovsky, President & CEO of Caliper Life Sciences
Caliper Life Sciences combines microfluidics, liquid handling and laboratory automation to deliver research tools for drug discovery and development, and […]
Read more »Biosphere-DuPont Collaboration May Create Higher-Margin Microspheres
BioSphere Medical, which has an FDA approved method to treat symptomatic uterine fibroids using microsphere technology, has signed an agreement […]
Read more »Applied NeuroSolutions’ Test Predicts Disease Progression from Mild Cognitive Impairment to Alzheimer’s Disease
Mild cognitive impairment (MCI) affects many areas of cognition including language, attention, reasoning, and judgment. Many view MCI a transitional […]
Read more »AngioDynamics Technology Not Responsible for Lung Tumor Treatment Deaths
In February 2003, the FDA’s General and Plastic Surgery Devices Advisory Committee met and discussed thermal ablation of lung tumors. […]
Read more »FDA Approves ATS’ AP360 Mechanical Heart Valve
The latest addition to ATS Medical’s suite of mechanical heart valve offerings, the AP360, has been approved for use in […]
Read more »[Video] Interview with Charles Fleischman, Former President of Digene
In this interview, Charles Fleischman, former President, CFO, and COO of Digene, discusses building a company and taking a product […]
Read more »San Francisco Finance Forum Panels on Funding Growth
The OneMedPlace 2008 Finance Forum has organized panels focused on funding the growth of healthcare and life science companies. These panels […]
Read more »[Video Profile] Ray Krauss, CEO of GlucoLight
Blood glucose levels have been called the next vital sign in the surgical environment. Numerous studies show that aggressive management […]
Read more »